Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2018 | 1 |
2019 | 2 |
2021 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study.
Lancet. 2019 Dec 7;394(10214):2096-2107. doi: 10.1016/S0140-6736(19)32556-5. Epub 2019 Nov 14.
Lancet. 2019.
PMID: 31735560
Clinical Trial.
Therapeutic Opportunities with Pharmacological Inhibition of CD38 with Isatuximab.
Martin TG, Corzo K, Chiron M, Velde HV, Abbadessa G, Campana F, Solanki M, Meng R, Lee H, Wiederschain D, Zhu C, Rak A, Anderson KC.
Martin TG, et al. Among authors: corzo k.
Cells. 2019 Nov 26;8(12):1522. doi: 10.3390/cells8121522.
Cells. 2019.
PMID: 31779273
Free PMC article.
Review.
Item in Clipboard
A phase 2 study of isatuximab monotherapy in patients with multiple myeloma who are refractory to daratumumab.
Mikhael J, Belhadj-Merzoug K, Hulin C, Vincent L, Moreau P, Gasparetto C, Pour L, Spicka I, Vij R, Zonder J, Atanackovic D, Gabrail N, Martin TG, Perrot A, Bensfia S, Weng Q, Brillac C, Semiond D, Macé S, Corzo KP, Leleu X.
Mikhael J, et al. Among authors: corzo kp.
Blood Cancer J. 2021 May 12;11(5):89. doi: 10.1038/s41408-021-00478-4.
Blood Cancer J. 2021.
PMID: 33980831
Free PMC article.
Clinical Trial.
No abstract available.
Item in Clipboard
Isatuximab plus pomalidomide/dexamethasone versus pomalidomide/dexamethasone in relapsed/refractory multiple myeloma: ICARIA Phase III study design.
Richardson PG, Attal M, Campana F, Le-Guennec S, Hui AM, Risse ML, Corzo K, Anderson KC.
Richardson PG, et al. Among authors: corzo k.
Future Oncol. 2018 May;14(11):1035-1047. doi: 10.2217/fon-2017-0616. Epub 2017 Dec 22.
Future Oncol. 2018.
PMID: 29268619
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite